TY - JOUR
T1 - Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis
AU - Bokhari, Sabahat
AU - Morgenstern, Rachelle
AU - Weinberg, Richard
AU - Kinkhabwala, Mona
AU - Panagiotou, Demetrios
AU - Castano, Adam
AU - DeLuca, Albert
AU - Andrew, Kontak
AU - Jin, Zhezhen
AU - Maurer, Mathew S.
N1 - Publisher Copyright: © 2016, American Society of Nuclear Cardiology.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Background: Technetium pyrophosphate (99mTc-PYP) imaging to diagnose transthyretin cardiac amyloidosis (ATTR-CA) has been increasingly utilized. The objective of this study is to provide a standardized 99mTc-PYP imaging protocol to diagnose ATTR-CA. Methods: 104 scans from 45 subjects with biopsy-proven ATTR-CA or light-chain cardiac amyloidosis (AL) were assessed. Multiple scans were obtained using different counts (750 vs 2000 K), times to acquisition (1 vs 2 to 4 hours), processing matrix (256 vs 128), and 99mTc-PYP dose. Image quality and extracardiac activity was assessed. Quantitative methods using heart-to-contralateral ratios (H/CL) and a visual semiquantitative scale were used to diagnose ATTR-CA.19 The correlation between H/CL ratios and reproducibility of semiquantitative visual scores, acquired using various imaging parameters, were evaluated. Results: All imaging parameters had good to excellent image quality. 750 vs 2000 K counts, 1 hour acquisition and 256 matrix, had lower extracardiac activity (P = .00018). 10 mCi of 99mTc-PYP v. higher doses showed excellent image quality and less extracardiac activity (P = .0015). Correlation of H/CL ratios was strong (r ≥ 0.92) and reproducibility of semiquantitative visual scores was high (Kappa = 95%). Conclusion: An imaging protocol using 750 K counts, 10 mCi of 99mTc-PYP, and a 256 matrix was chosen as the standardized imaging protocol since it provided the shortest overall study time (1 vs 2 to 4 hours) and lowest radiation exposure (3 vs 8 to 10 mSv).
AB - Background: Technetium pyrophosphate (99mTc-PYP) imaging to diagnose transthyretin cardiac amyloidosis (ATTR-CA) has been increasingly utilized. The objective of this study is to provide a standardized 99mTc-PYP imaging protocol to diagnose ATTR-CA. Methods: 104 scans from 45 subjects with biopsy-proven ATTR-CA or light-chain cardiac amyloidosis (AL) were assessed. Multiple scans were obtained using different counts (750 vs 2000 K), times to acquisition (1 vs 2 to 4 hours), processing matrix (256 vs 128), and 99mTc-PYP dose. Image quality and extracardiac activity was assessed. Quantitative methods using heart-to-contralateral ratios (H/CL) and a visual semiquantitative scale were used to diagnose ATTR-CA.19 The correlation between H/CL ratios and reproducibility of semiquantitative visual scores, acquired using various imaging parameters, were evaluated. Results: All imaging parameters had good to excellent image quality. 750 vs 2000 K counts, 1 hour acquisition and 256 matrix, had lower extracardiac activity (P = .00018). 10 mCi of 99mTc-PYP v. higher doses showed excellent image quality and less extracardiac activity (P = .0015). Correlation of H/CL ratios was strong (r ≥ 0.92) and reproducibility of semiquantitative visual scores was high (Kappa = 95%). Conclusion: An imaging protocol using 750 K counts, 10 mCi of 99mTc-PYP, and a 256 matrix was chosen as the standardized imaging protocol since it provided the shortest overall study time (1 vs 2 to 4 hours) and lowest radiation exposure (3 vs 8 to 10 mSv).
KW - ATTR-CA
KW - Tc-PYP
KW - amyloid
KW - amyloidosis
KW - non-invasive
KW - standardized imaging protocol
UR - http://www.scopus.com/inward/record.url?scp=84984833785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84984833785&partnerID=8YFLogxK
U2 - 10.1007/s12350-016-0610-4
DO - 10.1007/s12350-016-0610-4
M3 - Article
C2 - 27580616
SN - 1071-3581
VL - 25
SP - 181
EP - 190
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
IS - 1
ER -